Automated Insulin Delivery Significantly Lowered A1c for Patients With T2D

Automated insulin delivery significantly lowered hemoglobin A_1c (HbA_1c) levels for patients with type 2 diabetes (T2D), according to data published in JAMA Network Open.¹ The researchers’ findings led them to suggest automated insulin delivery as a safe and effective treatment option for patients with T2D using insulin.

“Diabetes is a major public health concern, affecting more than 38 million Americans, with high rates of morbidity and mortality. Despite the growing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose transport protein 2 inhibitors (SGLT-2is), many individuals with T2D have hemoglobin A_1c (HbA_1c)…